Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 16,362 shares at $14.86 ($235K) on 2023-11-21, disclosed to the SEC on 2023-11-22.
Open-market sale of $235k OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.86 | 4,192 | $62K | 26.5% |
| 2 | $14.86 | 4,192 | $62K | 26.5% |
| 3 | $13.90 | 3,989 | $55K | 23.5% |
| 4 | $13.90 | 3,989 | $55K | 23.5% |
| Total | $14.39 avg | 16,362 | $235K | 100% |
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |